ALICIA SALLOT: Open Payments
NPI 1063036580 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 75 payments from 12 companies in 2025. Trend: 2023 $687 · 2024 $606 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $310 |
| ABBVIE INC. | 19 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $173 |
| Aimmune Therapeutics, Inc. | 11 | $161 |
| Phathom Pharmaceuticals, Inc. | 7 | $86 |
| Ardelyx, Inc. | 3 | $71 |
| ViiV Healthcare Company | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| GENZYME CORPORATION | 3 | $47 |
| Organon LLC | 2 | $34 |
Products named: REZDIFFRA, ENTYVIO, VOWST, SKYRIZI, VOQUEZNA, IBSRELA, DUPIXENT, RINVOQ.
Industry payments across OH — which companies pay providers there.
